{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:54:24Z","timestamp":1792659264661,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,12]],"date-time":"2011-06-12T00:00:00Z","timestamp":1307836800000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.pnpbp.2010.06.004","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T04:31:08Z","timestamp":1276489868000},"page":"1104-1114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":219,"title":["Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine"],"prefix":"10.1016","volume":"34","author":[{"given":"Ronise M.","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna","family":"Barbieiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia A.","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.06.004_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","article-title":"Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease","volume":"4","author":"Bjorklund","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1471-4159.2002.00799.x","article-title":"The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma","volume":"81","author":"Castano","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib4","first-page":"133","article-title":"Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo","author":"Ceravolo","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0891988707301866","article-title":"Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample","volume":"20","author":"Chen","year":"2007","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1037\/0735-7044.120.6.1279","article-title":"Place learning strategy of substantia nigra pars compacta-lesioned rats","volume":"120","author":"Da Cunha","year":"2006","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2004.09.013","article-title":"Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment","volume":"48","author":"Dremencov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","article-title":"The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery","volume":"22","author":"Dutta","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(84)90028-1","article-title":"Acute administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP","volume":"101","author":"Enz","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00213-008-1070-6","article-title":"Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study","volume":"197","author":"Kobayashi","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib15","first-page":"377","article-title":"A new model of an experimental depressive syndrome in rats induced by the systemic administration to the animals of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"45","author":"Kryzhanovskii","year":"1995","journal-title":"Zh Vyssh Nerv Deiat Im IP Pavlova"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: a register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00536.x","article-title":"Depression in Parkinson's disease\u2014a review","volume":"113","author":"Lieberman","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib20","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1371\/journal.pone.0000513","article-title":"The role of the substantia nigra pars compacta in regulating sleep patterns in rats","volume":"2","author":"Lima","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2006.01.010","article-title":"Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally","volume":"199","author":"Ling","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/jnp.6.4.428","article-title":"Frontal lobe dysfunction in secondary depression","volume":"6","author":"Mayberg","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Suppl:20\u201323","key":"10.1016\/j.pnpbp.2010.06.004_bib25","first-page":"24","article-title":"Depression in the patient with Parkinson's disease","volume":"51","author":"Mayeux","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib26","first-page":"241","article-title":"Depression and Parkinson's disease","volume":"40","author":"Mayeux","year":"1984","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11920-006-0029-8","article-title":"Treatment of depression in Parkinson's disease","volume":"8","author":"Menza","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mds.21376","article-title":"Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor","volume":"22","author":"Miller","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1073858404266776","article-title":"Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry","volume":"10","author":"Owen","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/B:NEAB.0000009207.38914.2b","article-title":"Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters)","volume":"34","author":"Pankova","year":"2004","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02244188","article-title":"An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress","volume":"104","author":"Papp","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib33","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2008.03679.x","article-title":"The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry","volume":"1155","author":"Pierucci","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2007.08.024","article-title":"Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease","volume":"167","author":"Reksidler","year":"2008","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib39","first-page":"259","article-title":"Distinct effects of intranigral l-DOPA Infusion in the MPTP rat model of Parkinson's disease","volume":"73","author":"Reksidler","year":"2009","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-4328(02)00203-6","article-title":"In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/NA antidepressant treatments may produce greater effects than selective drugs","volume":"136","author":"Reneric","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0891-0618(00)00066-1","article-title":"Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach","volume":"20","author":"Schmitz","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson's disease\u2014an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF03033456","article-title":"Neurotoxins and neurotoxic species implicated in neurodegeneration","volume":"6","author":"Segura Aguilar","year":"2004","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib46","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archneur.1997.00550170097020","article-title":"Risk factors for depression in Parkinson disease","volume":"54","author":"Tandberg","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(00)02960-7","article-title":"Increased striatal dopamine turnover following acute administration of rotenone to mice","volume":"885","author":"Thiffault","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/jpet.102.037614","article-title":"2\u2032-NH(2)-MPTP [1-methyl-4-(2\u2032-aminophenyl)-1, 2, 3, 6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2\u2032-CH(3)-MPTP [1-methyl-4-(2\u2032-methylphenyl)-1, 2, 3, 6-tetrahydropyridine]","volume":"303","author":"Unger","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0269881108089814","article-title":"Anhedonia and activity deficits in rats: impact of post-stroke depression","volume":"23","author":"Wang","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.06.004_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav Brain Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610002216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610002216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:41:59Z","timestamp":1759520519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610002216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0278584610002216"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}